NasdaqGS:MNMDPharmaceuticals
Assessing Mind Medicine (MNMD)’s Valuation After a Strong Recent Share Price Rally
Mind Medicine (MindMed) (MNMD) has quietly turned into one of the more interesting brain health names this year, with the stock up roughly 66% year to date and nearly 39% over the past 3 months.
See our latest analysis for Mind Medicine (MindMed).
That kind of move, including a roughly 38.7% 3 month share price return on top of a 75.1% one year total shareholder return, signals momentum building as investors warm to its brain health pipeline and clinical milestones.
If MindMed has caught your...